erectile dysfunction
Conditions
Interventions
Endocvascular therapy including drug-eluting stent implantation to stenosed or occluded pelvic arteries (mainly inferior pudendal arteries).
Sponsors
Chiba University Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Patients with moderate or severe ED (IIEF more than / equal 12 at baseline) 2. Patients with stenotic or occluded erectile associated arteries detected by contrast enhanced computed tomography
Exclusion criteria
Exclusion criteria: 1. Patients with known other etiologies of ED 2. Untreated stenotic / occluded lesions in iliac arteries 3. Jailed internal iliac arteries by stents implanted in common / external iliac arteries 4. History of surgical treatment of iliac arteries 5. Patients with controversy for or poor adherence to dual antiplatelet therapy 6. Patients with untreated coronary artery disease 7. Patients with left ventricular dysfuinction (LVEF less than 40%) 8. Patients with severe chronic kidney disease (eg. serum creatinine level more than 2.0mg/dL)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy of endovascular therapy within 6 months. The maximum score in monthly investigation of International Index of Erectile Function 5 (IIEF5, a well-known subjective classification of ED) will be compared with baseline. | — |
Secondary
| Measure | Time frame |
|---|---|
| Efficacy of endovascular therapy at 6 months. The IIEF5 score at 6th month will be compared with baseline. | — |
Countries
Japan
Contacts
Public ContactYo Iwata
Chiba University Hospital Center for Cardiovascular Interventions
Outcome results
None listed